# FDA Inspection 631027 - Eurofins Lancaster Laboratories, Inc - October 06, 2009

Source: https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/28f6d683-eeef-4e09-8a37-3028ff535f1f
Source feed: FDA_Inspections

> FDA Inspection 631027 for Eurofins Lancaster Laboratories, Inc on October 06, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 631027
- Company Name: Eurofins Lancaster Laboratories, Inc
- Inspection Date: 2009-10-06
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1284580 - 2025-09-23](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/d905bc5d-0d6c-4d5e-b731-266193c1d3d1)
- [FDA Inspection 1284580 - 2025-09-23](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/35146b05-5a24-4e26-8820-288e62f4209b)
- [FDA Inspection 1279557 - 2025-08-26](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/204a3e19-1058-4e10-b09a-d0d509c4df22)
- [FDA Inspection 1156933 - 2021-10-21](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/4d87f249-7742-43a1-954b-3158e3a5047a)
- [FDA Inspection 1156933 - 2021-10-21](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/f3ad05fc-9ab4-40d0-b37f-c5f61e8ee8d5)

Company: https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/fdb282e8-01fc-4626-8794-1b7394ba0890

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c